Retired pharmaceutical exec reveals truth about drug development
By IHR Magazine, . Updated
With his new book, “Nesiritide: The Rise and Fall of Scios,” Roger M. Mills, M.D., aims to inform the general public about the inner workings of the pharmaceutical industry. Specifically, he gives readers an inside look into the development, early success and subsequent demise of a biotechnology drug that he helped to develop.
“‘Nesiritide’” gives the non-medical public an unprecedented insight into the complexity, risk, and competitiveness of drug development,” Mills said. “It demonstrates the devastating impact of media attention to questions of drug safety.”
Before his work at Scios Inc., Miller practiced as an academic clinical cardiologist. He joined Scios, a Johnson & Johnson operating company, in 2005, and layer moved on to Johnson & Johnson’s Janssen Research & Development, LLC as a senior director in clinical research. Since this time, Mills has adopted the mission to better inform the medical community and the public about the often-mysterious pharmaceutical industry.
For more information, visit http://www.rmillsmd.com/.
Sections: Industry News
More in Industry News
- Jungbunzlauer’s New Director Lands in the Middle of a Citric Acid Duty Fight
- NHP labelling Bulletin 13 turns two relabels into one reprint
- CHFA Launch Pad 2026 : deux finalistes québécois, et ni l’un ni l’autre n’a besoin d’une licence de Santé Canada
- CHFA Launch Pad 2026: Canada’s Innovation Pipeline Has Left the Supplement Aisle
- Retailers Want Inventory AI. Almost None Have It.
- The Ingredient Aisle Is Reorganising Around Proof — and That’s Where Niche Retailers Win